Abstract: Provided is a kit for rapid detection of avian leukosis virus subgroup J (ALV-J) based on a CRISPR/Cas13a system. The method is based on the combination of the CRISPR/Cas13a system and recombinase aided amplification (RAA) for ALV-J detection. An oligonucleotide probe is designed as a substrate for CRISPR/Cas13a trans-cleavage and produces a detectable signal. The method can substantially improve detection sensitivity by amplifying a detection signal twice by RAA and T7 transcription. The detection method further exhibits excellent specificity, allowing for clear differentiate from other avian viruses. It does not require expensive experimental equipment and special laboratory environment, and it is rapid and efficient. The method is of great significance for biological research and on-site detection of ALV-J.

Abstract: A method and an equipment for comprehensive utilization of niobite is disclosed. The method includes the following steps: S1. adding and uniformly mixing a coal-based reducing agent to the niobite, and subsequently reducing the mixture in a reduction furnace to obtain the selective reduction product; S2. adding the selective reduction product to a super-gravity reactor where the ambient temperature is controlled to be lower than the temperature at which the niobium oxide is reduced; driven by super-gravity, reverse migrating and collecting the metal iron and the niobium-rich slag at different locations in the reactor; discharging the metallic iron tightly attached to the wall of the reactor through an iron discharging port, and discharging the niobium-rich slag enriched to the inner layer of the reactor through a slag discharging port, so that the separation of the metallic iron and the niobium-rich slag is realized in the super-gravity field.

Abstract: The present invention relates to the field of biotechnology, in particular to a DNA polymerase mutant and the use thereof. Compared with a wild type, the mutant provided in the present invention has a significantly improved DNA polymerization activity, significantly improved affinity to DNA and amplification uniformity; and has good effects in the amplification of multiplex PCR, high-GC templates and complex templates. A hot-start-version DNA polymerase is further prepared by means of using antibodies or chemical modifications, wherein the yield of the DNA polymerase is significantly improved, while the primer dimer is significantly decreased. The prepared mutant hot-start DNA polymerase can be applied to PCR amplification of multiplex PCR, high-GC templates and complex templates.

Abstract: A method and an equipment for comprehensive utilization of niobite is disclosed. The method includes the following steps: S1. adding and uniformly mixing a coal-based reducing agent to the niobite, and subsequently reducing the mixture in a reduction furnace to obtain the selective reduction product; S2. adding the selective reduction product to a super-gravity reactor where the ambient temperature is controlled to be lower than the temperature at which the niobium oxide is reduced; driven by super-gravity, reverse migrating and collecting the metal iron and the niobium-rich slag at different locations in the reactor; discharging the metallic iron tightly attached to the wall of the reactor through an iron discharging port, and discharging the niobium-rich slag enriched to the inner layer of the reactor through a slag discharging port, so that the separation of the metallic iron and the niobium-rich slag is realized in the super-gravity field.

Abstract: The present disclosure relates to a composite membrane and a packaging structure. The composite membrane comprises: a carrier layer; and an information layer, wherein the information layer is disposed on one side of the carrier layer along thickness direction of the composite membrane, and the information layer further comprises a light-transmitting layer, a first pattern layer, and a second pattern layer, which are disposed along the thickness direction of the composite membrane, wherein: the first pattern layer is disposed close to the carrier layer; the light-transmitting layer is disposed on one side of the first pattern facing layer away from the carrier layer; the second pattern layer is disposed on one side of the light-transmitting layer facing away from the carrier layer, and the second pattern layer and the first pattern layer present different visual information of one multi-dimensional object.

Abstract: The present disclosure relates to a composite membrane and a packaging structure. The composite membrane comprises: a carrier layer; and an information layer, wherein the information layer is disposed on one side of the carrier layer along thickness direction of the composite membrane, and the information layer further comprises a light-transmitting layer, a first pattern layer, and a second pattern layer, which are disposed along the thickness direction of the composite membrane, wherein: the first pattern layer is disposed close to the carrier layer; the light-transmitting layer is disposed on one side of the first pattern facing layer away from the carrier layer; the second pattern layer is disposed on one side of the light-transmitting layer facing away from the carrier layer, and the second pattern layer and the first pattern layer present different visual information of one multi-dimensional object.

Abstract: A double-effective vaccine vector against foot-and-mouth disease virus having a bicistronic expression vector sequence, the bicistronic expression vector sequence is an antisense gene sequence capable of conjugating with 5? UTR of RNA of the foot-and-mouth disease virus genome and an intact sequence of VP1 structural protein gene of the foot-and-mouth disease virus. Animal experiments show that the vaccine vector provides double effects in terms of gene therapy and gene immunization for the prevention and treatment of foot-and-mouth disease in animals. Also provided are construction methods and methods of use of the vaccine vector.

Abstract: A double-effective vaccine vector against foot-and-mouth disease virus having a bicistronic expression vector sequence, the bicistronic expression vector sequence is an antisense gene sequence capable of conjugating with 5? UTR of RNA of the foot-and-mouth disease virus genome and an intact sequence of VP1 structural protein gene of the foot-and-mouth disease virus. Animal experiments show that the vaccine vector provides double effects in terms of gene therapy and gene immunization for the prevention and treatment of foot-and-mouth disease in animals. Also provided are construction methods and methods of use of the vaccine vector.